VanEck ETF Trust - VanEck Pharmaceutical ETF
US ˙ NasdaqGM ˙ US92189F6925

SecurityPPH / VanEck ETF Trust - VanEck Pharmaceutical ETF
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership67,086 shares
Latest Disclosed Value $ 6,968,894
Citadel Advisors Llc ownership in PPH / VanEck ETF Trust - VanEck Pharmaceutical ETF

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 67,086 shares of VanEck ETF Trust - VanEck Pharmaceutical ETF (US:PPH) valued at $6,968,894 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 0 shares of VanEck ETF Trust - VanEck Pharmaceutical ETF. The current value of the position is $7,094,344 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (PPH) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

PPH / VanEck ETF Trust - VanEck Pharmaceutical ETF Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 67,086 67,086 6,969 0.0010
2026-02-17 2025-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 0 -100.00 0
2025-11-14 2025-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 56,184 24,907 79.63 5,077 84.51 0.0007
2025-08-14 2025-06-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 31,277 -10,135 -24.47 2,751 -27.09 0.0005
2025-05-15 2025-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 41,412 12,875 45.12 3,774 53.25 0.0007
2025-02-14 2024-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 28,537 -35,813 -55.65 2,462 -59.74 0.0004
2024-11-14 2024-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 64,350 64,350 6,115 0.0012
2024-08-14 2024-06-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 0 -53,227 -100.00 0 -100.00
2024-05-15 2024-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 53,227 4,051 8.24 4,828 20.64 0.0009
2024-02-14 2023-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 49,176 24,656 100.55 4,001 104.34 0.0008
2023-11-14 2023-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 24,520 -12,913 -34.50 1,958 -33.58 0.0004
2023-08-14 2023-06-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 37,433 11,920 46.72 2,949 48.89 0.0006
2023-05-15 2023-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 25,513 -4,808 -15.86 1,981 -15.99 0.0004
2023-02-14 2022-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 30,321 -31,239 -50.75 2,357 -43.05 0.0006
2022-11-14 2022-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 61,560 61,560 4,139 0.0009
2022-08-15 2022-06-30 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 0 -12,120 -100.00 0 -100.00
2022-05-16 2022-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 12,120 -23,395 -65.87 967 -64.62 0.0002
2022-02-14 2021-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF 92189F692 35,515 -13,500 -27.54 2,733 -23.32 0.0006
2021-11-15 2021-09-30 13F VANECK ETF TRUST Cmn 92189F692 49,015 -16,013 -24.62 3,564 -24.97 0.0007
2021-08-16 2021-06-30 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 65,028 7,279 12.60 4,750 19.17 0.0011
2021-05-21 2021-03-31 13F/A-1 VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 57,749 39,171 210.85 3,986 222.75 0.0010
2021-05-17 2021-03-31 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 57,749 39,171 3,986 0.0010
2021-02-16 2020-12-31 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 18,578 -45,035 -70.80 1,235 -68.77 0.0003
2020-11-16 2020-09-30 13F VANECK VECTORS ETF TR PHARMACEUTICAL 92189F692 63,613 25,616 67.42 3,955 67.16 0.0011
2020-08-14 2020-06-30 13F VANECK VECTORS ETF TR Cmn 92189F692 37,997 -3,197 -7.76 2,366 5.58 0.0008
2020-05-15 2020-03-31 13F VANECK VECTORS ETF TR Cmn 92189F692 41,194 -7,075 -14.66 2,241 -27.66 0.0010
2020-02-14 2019-12-31 13F VANECK VECTORS ETF TRUST Cmn 92189F692 48,269 -808 -1.65 3,098 10.96 0.0013
2019-11-14 2019-09-30 13F VANECK VECTORS ETF TR Cmn 92189F692 49,077 -12,689 -20.54 2,792 -22.94 0.0013
2019-08-14 2019-06-30 13F VANECK VECTORS ETF TR Cmn 92189F692 61,766 38,920 170.36 3,623 161.21 0.0017
2019-05-15 2019-03-31 13F VANECK VECTORS ETF TR Cmn 92189F692 22,846 -57,258 -71.48 1,387 -68.56 0.0007
2019-02-14 2018-12-31 13F VANECK VECTORS ETF TR Cmn 92189F692 80,104 56,569 240.36 4,411 191.35 0.0024
2018-11-13 2018-09-30 13F VANECK VECTORS ETF TR Cmn 92189F692 23,535 -25,894 -52.39 1,514 -48.08 0.0007
2018-08-14 2018-06-30 13F/A-1 VANECK VECTORS ETF TR Cmn 92189F692 49,429 29,951 153.77 2,916 163.89 0.0014
2018-08-10 2018-06-30 13F VANECK VECTORS ETF TR Cmn 92189F692 49,429 29,951 2,916
2018-05-14 2018-03-31 13F/A-1 VANECK VECTORS ETF TR Cmn 92189F692 19,478 1,966 11.23 1,105 6.25 0.0006
2018-05-11 2018-03-31 13F VANECK VECTORS ETF TR Cmn 92189F692 19,478 1,966 1,105
2018-02-09 2017-12-31 13F VANECK VECTORS ETF TR Cmn 92189F692 17,512 -998 -5.39 1,040 -2.71 0.0006
2017-11-09 2017-09-30 13F VANECK VECTORS ETF TR Cmn 92189F692 18,510 -2,343 -11.24 1,069 -13.23 0.0008
2017-08-11 2017-06-30 13F VANECK VECTORS ETF TR Cmn 92189F692 20,853 6,141 41.74 1,232 51.91 0.0010
2017-05-12 2017-03-31 13F VANECK VECTORS ETF TR Cmn 92189F692 14,712 -8,463 -36.52 811 -33.36 0.0007
2017-02-10 2016-12-31 13F VANECK VECTORS ETF TR Cmn 92189F692 23,175 -22,671 -49.45 1,217 -53.80 0.0012
2017-01-31 2016-09-30 13F/A-1 VANECK VECTORS ETF TR Cmn 92189F692 45,846 37,801 469.87 2,634 459.24 0.0026
2016-11-10 2016-09-30 13F VANECK VECTORS PHARMACEUTICAL Cmn 92189F692 45,846 2,634
2017-01-31 2016-06-30 13F/A-1 VANECK VECTORS ETF TR Cmn 92189F692 8,045 8,045 471 0.0005
2016-08-12 2016-06-30 13F VANECK VECTORS PHARMACEUTICAL Cmn 92189F692 8,045 471 0.0005
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF Call 0 -100.00 0 n/a n/a n/a
2026-02-17 2025-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF Call 3,200 330 n/a n/a n/a
2025-11-14 2025-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-14 2025-06-30 13F VANECK ETF TRUST PHARMACEUTCL ETF Call 6,100 165.22 537 156.46 n/a n/a n/a
2025-05-15 2025-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF Call 2,300 4.55 210 10.58 n/a n/a n/a
2025-02-14 2024-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF Call 2,200 120.00 190 98.95 n/a n/a n/a
2024-11-14 2024-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF Call 1,000 -23.08 95 -19.49 n/a n/a n/a
2024-08-14 2024-06-30 13F VANECK ETF TRUST PHARMACEUTCL ETF Call 1,300 -7.14 119 -6.35 n/a n/a n/a
2024-05-15 2024-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF Call 1,400 366.67 127 425.00 n/a n/a n/a
2024-02-14 2023-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF Call 300 0.00 24 4.35 n/a n/a n/a
2023-11-14 2023-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF Call 300 -89.66 24 -89.91 n/a n/a n/a
2023-08-14 2023-06-30 13F VANECK ETF TRUST PHARMACEUTCL ETF Call 2,900 -48.21 228 -47.47 n/a n/a n/a
2023-05-15 2023-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF Call 5,600 2,700.00 435 2,793.33 n/a n/a n/a
2023-02-14 2022-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF Call 200 -99.48 16 -99.42 n/a n/a n/a
2022-11-14 2022-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF Call 38,700 43.33 2,602 25.40 n/a n/a n/a
2022-08-15 2022-06-30 13F VANECK ETF TRUST PHARMACEUTCL ETF Call 27,000 2,075 n/a n/a n/a
2022-02-14 2021-12-31 13F VANECK ETF TRUST Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F VANECK ETF TRUST Cmn Call 3,800 276 n/a n/a n/a
2021-08-16 2021-06-30 13F VANECK VECTORS ETF TR PHARMACEUTICAL Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-21 2021-03-31 13F/A VANECK VECTORS ETF TR PHARMACEUTICAL Call 16,200 -15.18 1,118 -11.97 n/a n/a n/a
2021-05-17 2021-03-31 13F VANECK VECTORS ETF TR PHARMACEUTICAL Call 16,200 1,118 n/a n/a n/a
2021-02-16 2020-12-31 13F VANECK VECTORS ETF TR PHARMACEUTICAL Call 19,100 229.31 1,270 251.80 n/a n/a n/a
2020-11-16 2020-09-30 13F VANECK VECTORS ETF TR PHARMACEUTICAL Call 5,800 7.41 361 13.88 n/a n/a n/a
2019-08-14 2019-06-30 13F VANECK VECTORS ETF TR Cmn Call 5,400 -53.04 317 -54.58 n/a n/a n/a
2019-05-15 2019-03-31 13F VANECK VECTORS ETF TR Cmn Call 11,500 698 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF Put 0 -100.00 0 n/a n/a n/a
2026-02-17 2025-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF Put 5,600 -32.53 578 -22.96 n/a n/a n/a
2025-11-14 2025-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF Put 8,300 -36.15 750 -34.47 n/a n/a n/a
2025-08-14 2025-06-30 13F VANECK ETF TRUST PHARMACEUTCL ETF Put 13,000 -77.89 1,143 -78.67 n/a n/a n/a
2025-05-15 2025-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF Put 58,800 121.89 5,358 134.38 n/a n/a n/a
2025-02-14 2024-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF Put 26,500 2,550.00 2,286 2,306.32 n/a n/a n/a
2024-11-14 2024-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF Put 1,000 -16.67 95 -12.84 n/a n/a n/a
2024-08-14 2024-06-30 13F VANECK ETF TRUST PHARMACEUTCL ETF Put 1,200 -47.83 110 -47.60 n/a n/a n/a
2024-05-15 2024-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF Put 2,300 -82.71 209 -80.78 n/a n/a n/a
2024-02-14 2023-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF Put 13,300 850.00 1,082 874.77 n/a n/a n/a
2023-11-14 2023-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF Put 1,400 250.00 112 258.06 n/a n/a n/a
2023-08-14 2023-06-30 13F VANECK ETF TRUST PHARMACEUTCL ETF Put 400 -83.33 32 -83.33 n/a n/a n/a
2023-05-15 2023-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF Put 2,400 -11.11 186 -11.00 n/a n/a n/a
2023-02-14 2022-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF Put 2,700 210 n/a n/a n/a
2022-11-14 2022-09-30 13F VANECK ETF TRUST PHARMACEUTCL ETF Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F VANECK ETF TRUST PHARMACEUTCL ETF Put 4,300 0.00 330 -3.79 n/a n/a n/a
2022-05-16 2022-03-31 13F VANECK ETF TRUST PHARMACEUTCL ETF Put 4,300 10.26 343 14.33 n/a n/a n/a
2022-02-14 2021-12-31 13F VANECK ETF TRUST PHARMACEUTCL ETF Put 3,900 -20.41 300 -15.73 n/a n/a n/a
2021-11-15 2021-09-30 13F VANECK ETF TRUST Cmn Put 4,900 40.00 356 39.06 n/a n/a n/a
2021-08-16 2021-06-30 13F VANECK VECTORS ETF TR PHARMACEUTICAL Put 3,500 256 n/a n/a n/a
2020-11-16 2020-09-30 13F VANECK VECTORS ETF TR Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-14 2020-06-30 13F VANECK VECTORS ETF TR Cmn Put 8,000 -2.44 498 11.66 n/a n/a n/a
2020-05-15 2020-03-31 13F VANECK VECTORS ETF TR Cmn Put 8,200 -3.53 446 -18.32 n/a n/a n/a
2020-02-14 2019-12-31 13F VANECK VECTORS ETF TRUST Cmn Put 8,500 3.66 546 22.42 n/a n/a n/a
2017-02-10 2016-12-31 13F VANECK VECTORS PHARMACEUTICAL Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2016-09-30 13F/A VANECK VECTORS ETF TR Cmn Put 4,200 241 n/a n/a n/a
2016-11-10 2016-09-30 13F VANECK VECTORS PHARMACEUTICAL Cmn Put 4,200 241 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.